Jump to content

Yoram Harth

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by צחי לרנר (talk | contribs) at 22:52, 18 September 2015 (→‎Biography: added). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

File:Yoram Harth.png
Yoram Harth

Yoram Harth (Hebrew: יורם הרט; born 27 August 1958)[1][2] is an Israeli dermatologist and inventor. He co-invented blue light acne vulgaris phototherapy,[3][4][5][6][7][8][9][10][11] as well as a radio frequency device for home treatment for wrinkle reduction.[12][13][14][15][16][17]

He founded CureLight Medical Ltd. and served as its President and Medical Director.[3][4][6][11][18] He founded Endymed Medical Ltd. and currently serves as its Chief Medical Officer.[6][18]

Biography

Yoram Harth's father was a physician who specialised in internal medicine.[3] Harth's website says that he was a Magna cum Laude graduate of the Sackler School of Medicine in Tel Aviv University (1982). [19] [1] [2] [5] [20]

Harth received his Dermatology training in the department of Dermatology at Rambam Medical School in Haifa [20] [19] and served a research fellow in the department of Dermatology at the Columbia – Presbyterian Medical center in New York.[20] He won The Israeli Society of Dermatology Award for the best scientific study of 1992.[20] [19]

He co-founded the Phototherapy Unit, Rambam Medical center, and was Director of the Photodynamic Therapy Unit, Elisha Medical Center in Haifa.[1] [18] Harth served on the faculty of American Academy of Dermatology (AAD) as part of the Photobiology training team [6] [18] and the American Society for Laser Medicine and Surgery (ASLMS). [6] [19]

Harth holds several patents and has authored a number of papers and book chapters.[1][3] [20] [21] [22]

Scientific and business activity

Starting in 1998 Harth co-founded Curelight, an Israeli company, and developed Clearlight, an acne phototherapy therapy system.[3][4][5][7][8][9][11][20][19]

Curelight was chosen by the Israeli Venture Capital Association as Best Startup company of 2002 (Medical Devices).[20] Curelight was a finalist in the contest Entrepreneur of the year 2003, (Ernst & Young, Israel).[20]

Harth was also a pioneer in the development of other novel devices for dermatological treatment among them the patented invention in the field of targeted multi–wavelength phototherapy for psoriasis and Vitiligo.[3][4][6][23]

In 2007 Harth co-founded Endymed Medical and Israeli company specializing in multisource radiofrequency devices for the professional and home use markets. Harth and his co-founder developed the first ever radiofrequency technology that uses 6 phase controlled generators.[6] [12][24][25] This technology allows multiple aesthetetic treatments including painless skin tightening and lifting for the face and body. Fraction of a RF skin resurfacing for skin rejuvenation, acne scars and stretch and more. Endymed’s home use device was the world’s first energy based RF device to be approved by the FDA for home use facial wrinkle reduction.[12][14][15][17][25]

This device was a winner of the Edison Product innovation award for 2013. Endymed medical was the Europe fastest growing biomedical company on Deloitte Touche fast 500 competition held in October 2013 in London[14] [26] [27] and currently traded on the Tel Aviv Stock Exchange (ENDY:TASE).[15] [28][29]

References

  1. ^ a b c d Biography in skintricks.com
  2. ^ a b Biography in The Israeli skin site
  3. ^ a b c d e f "Skin Problems? Just A Light Zap Away!", Singapore Medical Grapevine – A Medical Practice Magazine + 2004/2005 special Issue , pp. 1, 20-21.
  4. ^ a b c d Tiebel, Amy (22 November 2002)."Special Report: Technology Innovation - Israeli Therapy Shines Light on Cure for Acne". The Wall Street Journal.
  5. ^ a b c Acne phototherapy using UV-free high-intensity narrow-band blue light: a three-center clinical study. Shalita, Alan R.; Harth, Yoram; Elman, Monica; Slatkine, Michael; Talpalariu, Gerry; Rosenberg, Yitzhak; Korman, Avner; Klein, Arieh. Proceedings of the SPIE, Volume 4244, p. 61-73 (2001) and also Cite error: The named reference "harvard" was defined multiple times with different content (see the help page).
  6. ^ a b c d e f g Biography in Endymed company site
  7. ^ a b Samten, Williams (June 2000). "Phototherapy Device for Acne Uses Visible Light." Dermatology Times. Vol. 21 Issue 6, p14.
  8. ^ a b Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. FEMS Immunol Med Microbiol 2003 Jan 21 35:1 17-24.
  9. ^ a b The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420 nm light source. Elman M, Harth Y, Slatkine M. J Cosmet Laser Ther. 2003 Jun;5(2):111-7.
  10. ^ patent number 6,835,202 - Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea
  11. ^ a b c Rave, Michal (8–9 March 2000). "ESC bought 10% of CureLight and innovative patent to treat Acne vulgaris". Globes. P. 5.
  12. ^ a b c Yeshayahou, Kobi (22 August 2013). "EndyMed soars on FDA approval". Globes.
  13. ^ Deloitte Israel Technology Fast 50 Archive, 2013 Issue
  14. ^ a b c Bloxham, Roger (9 December 2013). "EndyMed Medical Ltd ranks No 1 fastest growing Biotech/Pharmaceutical company on Deloitte’s Technology Fast 500 EMEA 2013". Aestheticare.co.uk
  15. ^ a b c Cohen, Tova (5 February 2015). "Israel's EndyMed a top stock on FDA wrinkle treatment approval". Reuters.
  16. ^ (September 2013). "EndyMed Medical is Proud to Announce That Its Newa™ Skin Care System Has Received the World’s First FDA Clearance for a Home Use, Energy Based, Wrinkle Reduction Device". prweb.com.
  17. ^ a b Petrou, Ilya (September 2010). "RF Innovation". Cosmetic Surgery Times. Vol. 14. No. 8. Pp 1, 4, 6-7.
  18. ^ a b c d Profile in Bloomberg
  19. ^ a b c d e Keynote Speakers in 2014 National Laser and Cosmetic Medicine conference, Sofitel Melbourne on Collins, 15–16 November 2014
  20. ^ a b c d e f g h Autobiography in his Israel Acne site
  21. ^ Harth's selected Publications List in publicationslist.org
  22. ^ List of Publications in Google Scholar
  23. ^ Treatment of localized Vitiligo and leukoderma with a UVB/UVA1 high density light system. Sadick N, Friedman D, Harth Y. Cosm Dermatol. 2004 Nov, 17:11, 723-726.
  24. ^ Novel Multi-Source Phase-Controlled Radiofrequency Technology for Nonablative and Micro-Ablative Treatment of Wrinkles, Lax Skin and Acne Scars Laser Therapy. 2011, Vol. 20, NO. 2, p.139-144.
  25. ^ a b McKinney, Sean. "Multi-Source RF Signifies New Era in Anti-Wrinkle and Skin Tightening Technology". The Aesthetic Guide (November–December 2009).
  26. ^ Nissan, Yossi. "3 Israeli tech cos make Deloitte European top ten". Globes (1 December 2013).
  27. ^ (3 December 2013). "EndyMed ranks No 1 fastest growing biotech/pharma company on Deloitte's Technology Fast 500 EMEA 2013." pharmabiz.com
  28. ^ Endymed Ltd in Bloomberg site
  29. ^ Endymed in Globes site
Retrieved from "https://en.wikipedia.org/w/index.php?title=Yoram_Harth&oldid=681701219"